Banner for leaf pages 2

Abciximab (Reopro)

Also known as Reopro

Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed abciximab to treat sharp chest pain, heart attack, rabies, and blastomycosis.

What drug interactions are known?

Do not take abciximab if you are taking any of the following:

Critical Interactions


Significant Interactions

Ajax-loader Loading...